Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David B. Riffe"'
Autor:
Collin D. Heer, Andrew B. Davis, David B. Riffe, Brett A. Wagner, Kelly C. Falls, Bryan G. Allen, Garry R. Buettner, Robert A. Beardsley, Dennis P. Riley, Douglas R. Spitz
Publikováno v:
Antioxidants, Vol 7, Iss 1, p 18 (2018)
Lung cancer, together with head and neck cancer, accounts for more than one-fourth of cancer deaths worldwide. New, non-toxic therapeutic approaches are needed. High-dose IV vitamin C (aka, pharmacological ascorbate; P-AscH−) represents a promising
Externí odkaz:
https://doaj.org/article/ceb651bc27ea41a49bd9dd8355de159b
Autor:
David B. Riffe, Kelly C. Falls, Robert A. Beardsley, Brett A. Wagner, Dennis P. Riley, Bryan G. Allen, Douglas R. Spitz, Garry R. Buettner, Collin D. Heer, Andrew B. Davis
Publikováno v:
Antioxidants; Volume 7; Issue 1; Pages: 18
Antioxidants, Vol 7, Iss 1, p 18 (2018)
Antioxidants, Vol 7, Iss 1, p 18 (2018)
Lung cancer, together with head and neck cancer, accounts for more than one-fourth of cancer deaths worldwide. New, non-toxic therapeutic approaches are needed. High-dose IV vitamin C (aka, pharmacological ascorbate; P-AscH-) represents a promising a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60b9654c0db1675b788c61164c11c68b
Autor:
Collin D, Heer, Andrew B, Davis, David B, Riffe, Brett A, Wagner, Kelly C, Falls, Bryan G, Allen, Garry R, Buettner, Robert A, Beardsley, Dennis P, Riley, Douglas R, Spitz
Publikováno v:
Antioxidants
Lung cancer, together with head and neck cancer, accounts for more than one-fourth of cancer deaths worldwide. New, non-toxic therapeutic approaches are needed. High-dose IV vitamin C (aka, pharmacological ascorbate; P-AscH−) represents a promising
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ac9da8aba3a7bd2f67aadfac5b65c333
https://pubmed.ncbi.nlm.nih.gov/29351198
https://pubmed.ncbi.nlm.nih.gov/29351198
Autor:
Collin D. Heer, Kranti A. Mapuskar, David B. Riffe, Raghuram Inturi, Doug Spitz, Kelly Hubert, Sebastian Sciegienka
Publikováno v:
Free Radical Biology and Medicine. 128:S66-S67
Due to tumor heterogeneity related to the inherent metabolic plasticity of cancer cells, attempts to target lung cancer metabolism thus far have yielded limited success. One potential solution to this problem is targeting of specific metabolites that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::967577283203d8f7d0007a5043b414f6
https://doi.org/10.1016/j.freeradbiomed.2018.10.138
https://doi.org/10.1016/j.freeradbiomed.2018.10.138
Autor:
Kelly C. Falls, Dennis P. Riley, David B. Riffe, Garry R. Buettner, Brett A. Wagner, Robert A. Beardsley, Douglas R. Spitz, Collin D. Heer, Bryan G. Allen, Andrew B. Davis
Publikováno v:
Free Radical Biology and Medicine. 112:90-91
Lung cancer accounts for approximately one-fourth of cancer deaths worldwide; new therapeutic approaches are desperately needed. An emerging adjuvant therapy currently in clinical trials is pharmacological ascorbate (P-AscH‒). The anti-cancer effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcfe0be293be6825a7293a84d2d9d56c
https://doi.org/10.1016/j.freeradbiomed.2017.10.132
https://doi.org/10.1016/j.freeradbiomed.2017.10.132